Mutation of lipoprotein processing pathway gene lspA or inhibition of LspA activity by globomycin increases MRSA resistance to β-lactam antibioticsVisa övriga samt affilieringar
2026 (Engelska)Ingår i: Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, E-ISSN 1098-6596, Vol. 70, nr 2, artikel-id e0127625Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Resistance to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus is mediated by the mecA-encoded, β-lactam-resistant transpeptidase, penicillin-binding protein 2a (PBP2a), which is capable of crosslinking peptidoglycan in the presence of β-lactam antibiotics. Here, we report that mutation of the lipoprotein signal peptidase II gene, lspA, from the lipoprotein processing pathway, significantly increased β-lactam resistance in MRSA, independent of changes in PBP2a levels or peptidoglycan composition. Exposure of MRSA to the LspA inhibitor globomycin also increased β-lactam resistance. Mutation of lgt, which encodes diacylglycerol transferase (Lgt) responsible for synthesis of the LspA substrate, did not impact β-lactam susceptibility. Furthermore, mutation of lgt in an lspA background restored β-lactam resistance to wild-type levels. These data suggest that accumulation of the LspA substrate, diacylglyceryl-lipoprotein, is associated with increased β-lactam resistance in MRSA.
Ort, förlag, år, upplaga, sidor
American Society for Microbiology, 2026. Vol. 70, nr 2, artikel-id e0127625
Nyckelord [en]
beta-lactam, globomycin, lipoprotein, MRSA, resistance
Nationell ämneskategori
Mikrobiologi inom det medicinska området
Identifikatorer
URN: urn:nbn:se:umu:diva-249934DOI: 10.1128/aac.01276-25ISI: 001649899800001PubMedID: 41459928Scopus ID: 2-s2.0-105029477089OAI: oai:DiVA.org:umu-249934DiVA, id: diva2:2039943
Forskningsfinansiär
Forskningsrådet Formas2026-02-192026-02-192026-02-19Bibliografiskt granskad